Supplementation with vitamin D improves the embryo quality in in vitro fertilization (IVF) programs, independently of the patients' basal vitamin D status
- PMID: 38580857
- PMCID: PMC11147876
- DOI: 10.1007/s00404-024-07473-7
Supplementation with vitamin D improves the embryo quality in in vitro fertilization (IVF) programs, independently of the patients' basal vitamin D status
Erratum in
-
Correction to: Supplementation with vitamin D improves the embryo quality in in vitro fertilization (IVF) programs, independently of the patients' basal vitamin D status.Arch Gynecol Obstet. 2024 Jun;309(6):2963. doi: 10.1007/s00404-024-07540-z. Arch Gynecol Obstet. 2024. PMID: 38700531 Free PMC article. No abstract available.
Abstract
Purpose: The study aims to demonstrate the effects of Vitamin D (VD) supplementation, prior to oocyte pick-up within IVF protocols, in women with diverse VD status at the enrollment.
Methods: A total of 204 women eligible for intra-cytoplasmatic sperm injection (ICSI) cycles were included in the study and two homogeneous groups were selected from the database. Both group of patients with normal VD baseline level (> 40 ng/ml) and patients with low VD baseline level (< 20 ng/ml) were divided into control group and treatment group. The control group followed the standard procedure. The treatment group was supplemented with vitamin D3 as cholecalciferol in combination with Myo-Inositol, folic acid, and melatonin 3 months before standard procedure, once a day in the evening.
Results: VD levels significantly increased in the study group of low baseline VD, both in serum and in the follicular fluid compared to controls. The treatment induced a significant improvement of the embryo quality in both group of patients considered.
Conclusion: Supplementation of VD in patients undergoing ICSI procedures significantly improved the number of top-quality embryos compared with the control group, either starting from VD normal baseline values or starting from low values.
Trial registration number: 07/2018.
Keywords: Embryo quality; Endometrial thickness; ICSI; IVF outcomes; Progesterone levels; Vitamin D.
© 2024. The Author(s).
Conflict of interest statement
M. R., S. P., G. F. are employees of Lo.Li. pharma s.r.l.
Similar articles
-
Positive effect of a new supplementation of vitamin D3 with myo-inositol, folic acid and melatonin on IVF outcomes: a prospective randomized and controlled pilot study.Gynecol Endocrinol. 2021 Mar;37(3):251-254. doi: 10.1080/09513590.2020.1760820. Epub 2020 May 5. Gynecol Endocrinol. 2021. PMID: 32367738 Clinical Trial.
-
The effect of myo-inositol, vitamin D3 and melatonin on the oocyte quality and pregnancy in in vitro fertilization: a randomized prospective controlled trial.Eur Rev Med Pharmacol Sci. 2020 Aug;24(16):8529-8536. doi: 10.26355/eurrev_202008_22649. Eur Rev Med Pharmacol Sci. 2020. PMID: 32894558 Clinical Trial.
-
Vitamin D improves in-vitro fertilization outcomes in infertile women with polycystic ovary syndrome and insulin resistance.Minerva Med. 2019 Jun;110(3):199-208. doi: 10.23736/S0026-4806.18.05946-3. Epub 2019 Jan 4. Minerva Med. 2019. PMID: 30612423
-
Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature.Horm Mol Biol Clin Investig. 2018 Mar 2;34(2):/j/hmbci.2018.34.issue-2/hmbci-2017-0067/hmbci-2017-0067.xml. doi: 10.1515/hmbci-2017-0067. Horm Mol Biol Clin Investig. 2018. PMID: 29498933 Review.
-
Inositol for subfertile women with polycystic ovary syndrome.Cochrane Database Syst Rev. 2018 Dec 20;12(12):CD012378. doi: 10.1002/14651858.CD012378.pub2. Cochrane Database Syst Rev. 2018. PMID: 30570133 Free PMC article.
Cited by
-
Oocyte and dietary supplements: a mini review.Front Cell Dev Biol. 2025 Jun 26;13:1619758. doi: 10.3389/fcell.2025.1619758. eCollection 2025. Front Cell Dev Biol. 2025. PMID: 40641606 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical